EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical Characteristics, Long‐Term Outcomes, and Prognostic Factors in High‐and Very High‐Risk Prostate Cancer: A 25‐Year Institutional Cohort Study

Tomoyuki Shimabukuro iD, Hidekazu Tanaka iD, Masahiro Tanabe, Takanori Tokunaga iD, Kosuke Shimizu iD, Nakanori Fujii, Keita Kobayashi iD, Toshiya Hiroyoshi, Hiroshi Hirata iD, Koji Shiraishi iD

Advances in Urology · 2026-01 · 2026 (1)

DOI: 10.1155/aiu/9913238 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Advances in Urology, online erschienen am 17.08.2026. Verfasst von Tomoyuki Shimabukuro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan, yamaguchi-u.ac.jp. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective High‐ and very high‐risk prostate cancer (hvPCa) is associated with substantial prostate cancer–specific mortality, making optimal treatment selection challenging. This study reevaluated our 25‐year institutional experience with hvPCa to assess long‐term oncological outcomes and identify prognostic factors associated with survival.

Methods

We retrospectively analyzed 220 patients with hvPCa reclassified according to the latest National Comprehensive Cancer Network guidelines. Of these, 66 underwent radical prostatectomy (RP), 52 received radiotherapy plus androgen deprivation therapy (RT + ADT), and 102 received primary ADT. Long‐term oncological outcomes were compared across treatment modalities and risk groups. Prognostic factors associated with prostate cancer–specific survival (PCSS) were evaluated using Cox proportional hazards models.

Results

The median age was 71 years, and the median follow‐up duration was 88 months. During follow‐up, 49 patients (22.3%) died from any cause, and 19 (8.6%) died from prostate cancer. Among high‐risk patients, overall survival was significantly better in the RP group than in the ADT group (hazard ratio [HR]: 4.812; 95% confidence interval [CI]: 1.832–12.635; p = 0.001). Among very high‐risk patients, PCSS was significantly worse in the ADT group than in the RP group (HR: 2.899; 95% CI: 1.454–5.782; p = 0.003). Multivariable analysis identified ECOG performance status ≥ 2 (HR: 40.756; 95% CI: 1.846–899.767; p = 0.019) and biochemical recurrence (HR: 21.566; 95% CI: 1.079–430.937; p = 0.044) as independent predictors of poorer PCSS.

Conclusions

Poorer ECOG performance status and biochemical recurrence were independently associated with worse PCSS in patients with hvPCa. These findings highlight the prognostic importance of patient functional status in addition to conventional tumor‐related factors and may contribute to improved risk stratification and individualized treatment selection.

Schlagwörter

Stichwörter der Autor:innen

ECOG performance statusbiochemical recurrencehigh-risk prostate cancervery high-risk prostate cancer

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan, yamaguchi-u.ac.jp.
  • Department of Urology, Ube Central Hospital, Ube, Yamaguchi, Japan.
  • Department of Radiation Oncology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan, yamaguchi-u.ac.jp.
  • Department of Radiology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan, yamaguchi-u.ac.jp.

ORCID-Profile: Tomoyuki Shimabukuro, Hidekazu Tanaka, Takanori Tokunaga, Kosuke Shimizu, Keita Kobayashi, Hiroshi Hirata, Koji Shiraishi

Zitieren

APA

Shimabukuro, T., Tanaka, H., Tanabe, M., Tokunaga, T., Shimizu, K., Fujii, N., Kobayashi, K., Hiroyoshi, T., Hirata, H., & Shiraishi, K. (2026). Clinical Characteristics, Long‐Term Outcomes, and Prognostic Factors in High‐and Very High‐Risk Prostate Cancer: A 25‐Year Institutional Cohort Study. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/9913238

Vancouver

Shimabukuro T, Tanaka H, Tanabe M, Tokunaga T, Shimizu K, Fujii N, et al. Clinical Characteristics, Long‐Term Outcomes, and Prognostic Factors in High‐and Very High‐Risk Prostate Cancer: A 25‐Year Institutional Cohort Study. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/9913238

BibTeX
@article{Shimabukuro2026,
  author = {Shimabukuro, Tomoyuki and Tanaka, Hidekazu and Tanabe, Masahiro and Tokunaga, Takanori and Shimizu, Kosuke and Fujii, Nakanori and Kobayashi, Keita and Hiroyoshi, Toshiya and Hirata, Hiroshi and Shiraishi, Koji},
  title = {Clinical Characteristics, Long‐Term Outcomes, and Prognostic Factors in High‐and Very High‐Risk Prostate Cancer: A 25‐Year Institutional Cohort Study},
  journal = {Advances in Urology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/aiu/9913238}
}
Kostenlos starten →